These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

281 related items for PubMed ID: 15781314

  • 21. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
    Haeusler G, Walter I, Helmreich M, Egerbacher M.
    Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
    [Abstract] [Full Text] [Related]

  • 22. The biological role and regulation of matrix metalloproteinases (MMP) in cancer.
    Davidson B, Reich R, Risberg B, Nesland JM.
    Arkh Patol; 2002 May; 64(3):47-53. PubMed ID: 15338725
    [Abstract] [Full Text] [Related]

  • 23. [TIMPs (tissue inhibitors of metalloproteinases): their species, functions and effects on tumor metastasis].
    Yasumitsu H, Wakabayashi E, Kitajima H, Sakamoto Y, Miyazaki K.
    Nihon Rinsho; 1995 Jul; 53(7):1798-804. PubMed ID: 7630022
    [Abstract] [Full Text] [Related]

  • 24. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
    Zhang H, Stephens LC, Kumar R.
    Clin Cancer Res; 2006 Mar 01; 12(5):1479-86. PubMed ID: 16533771
    [Abstract] [Full Text] [Related]

  • 25. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
    Gueders MM, Foidart JM, Noel A, Cataldo DD.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):133-44. PubMed ID: 16487964
    [Abstract] [Full Text] [Related]

  • 26. Membrane type-matrix metalloproteinases and tumor progression.
    Sounni NE, Noel A.
    Biochimie; 2005 Mar 08; 87(3-4):329-42. PubMed ID: 15781320
    [Abstract] [Full Text] [Related]

  • 27. Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.
    Benekareddy M, Mehrotra P, Kulkarni VA, Ramakrishnan P, Dias BG, Vaidya VA.
    Synapse; 2008 Aug 08; 62(8):590-600. PubMed ID: 18509851
    [Abstract] [Full Text] [Related]

  • 28. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
    Janssens S, Lijnen HR.
    Cardiovasc Res; 2006 Feb 15; 69(3):585-94. PubMed ID: 16426591
    [Abstract] [Full Text] [Related]

  • 29. [Matrix metalloproteinases: Promoters of tumor invasion and metastasis - A review with focus on gastrointestinal tumors].
    Roeb E, Matern S.
    Z Gastroenterol; 2001 Sep 15; 39(9):807-13. PubMed ID: 11558074
    [Abstract] [Full Text] [Related]

  • 30. Suppression of PMA-induced tumor cell invasion by capillarisin via the inhibition of NF-kappaB-dependent MMP-9 expression.
    Lee SO, Jeong YJ, Kim M, Kim CH, Lee IS.
    Biochem Biophys Res Commun; 2008 Feb 22; 366(4):1019-24. PubMed ID: 18088599
    [Abstract] [Full Text] [Related]

  • 31. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Park HJ, Lee HJ, Min HY, Chung HJ, Suh ME, Park-Choo HY, Kim C, Kim HJ, Seo EK, Lee SK.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):31-6. PubMed ID: 16309669
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Expression of matrix metalloproteinases-1, -2, and -9; tissue inhibitors of matrix metalloproteinases-1 and -2; cathepsin B; urokinase plasminogen activator; and plasminogen activator inhibitor, type I in skull base chordoma.
    Naka T, Kuester D, Boltze C, Schulz TO, Samii A, Herold C, Ostertag H, Roessner A.
    Hum Pathol; 2008 Feb 19; 39(2):217-23. PubMed ID: 17949787
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2.
    Choi J, Choi K, Benveniste EN, Rho SB, Hong YS, Lee JH, Kim J, Park K.
    Cancer Res; 2005 Jul 01; 65(13):5554-60. PubMed ID: 15994927
    [Abstract] [Full Text] [Related]

  • 36. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
    Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW, Selander KS.
    Mol Cancer Res; 2006 Jul 01; 4(7):437-47. PubMed ID: 16849519
    [Abstract] [Full Text] [Related]

  • 37. Biological activity and clinical implications of the matrix metalloproteinases.
    Rydlova M, Holubec L, Ludvikova M, Kalfert D, Franekova J, Povysil C, Ludvikova M.
    Anticancer Res; 2008 Jul 01; 28(2B):1389-97. PubMed ID: 18505085
    [Abstract] [Full Text] [Related]

  • 38. New insights into the roles of matrix metalloproteinases in colorectal cancer development and progression.
    Leeman MF, Curran S, Murray GI.
    J Pathol; 2003 Dec 01; 201(4):528-34. PubMed ID: 14648655
    [Abstract] [Full Text] [Related]

  • 39. Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.
    Milner JM, Rowan AD, Cawston TE, Young DA.
    Arthritis Res Ther; 2006 Dec 01; 8(5):R142. PubMed ID: 16919164
    [Abstract] [Full Text] [Related]

  • 40. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK, Hwang YS, Park KK, Park HJ, Seo JY, Chung WY.
    Carcinogenesis; 2009 Jul 01; 30(7):1225-33. PubMed ID: 19420016
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.